Impact of Sterilization Technique on Incidence of Urinary Tract Infection After Cystoscopy

This study has been completed.
Sponsor:
Information provided by:
University of Minnesota - Clinical and Translational Science Institute
ClinicalTrials.gov Identifier:
NCT00177112
First received: September 13, 2005
Last updated: January 31, 2008
Last verified: January 2008
  Purpose

The purpose of this study is to verify that the incidence rate of urinary tract infections after a routine outpatient cystoscopy is the same for non-sterile (clean) and sterile procedural techniques.


Condition Intervention Phase
Urinary Tract Infections
Procedure: clean patient preparation for cystoscopy
Procedure: sterile patient preparation for cystoscopy
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Impact of Sterilization Technique on Incidence of Urinary Tract Infection After Cystoscopy

Resource links provided by NLM:


Further study details as provided by University of Minnesota - Clinical and Translational Science Institute:

Primary Outcome Measures:
  • To verify that the incidence rate of urinary tract infections after a routine outpatient cystoscopy is the same for non-sterile (clean) and sterile procedural techniques

Estimated Enrollment: 275
Study Start Date: June 2005
Study Completion Date: October 2007
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • 18 years of age or older
  • Patients undergoing routine outpatient flexible cystoscopy

Exclusion Criteria:

  • Patients who have had a urinary tract infection within 3 months prior to flexible cystoscopy
  • Patients with an indwelling catheter
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00177112

Locations
United States, Minnesota
VAMC Minneapolis
Minneapolis, Minnesota, United States, 55417
Sponsors and Collaborators
University of Minnesota - Clinical and Translational Science Institute
Investigators
Principal Investigator: Kyle Anderson, MD VAMC Minneapolis
  More Information

No publications provided

Responsible Party: Manoj Monga, MD, University of Minnesota
ClinicalTrials.gov Identifier: NCT00177112     History of Changes
Other Study ID Numbers: 0412M65852, 3519A
Study First Received: September 13, 2005
Last Updated: January 31, 2008
Health Authority: United States: Institutional Review Board

Keywords provided by University of Minnesota - Clinical and Translational Science Institute:
Cystoscopy

Additional relevant MeSH terms:
Infection
Communicable Diseases
Urinary Tract Infections
Urologic Diseases
Disinfectants
Anti-Infective Agents
Therapeutic Uses
Pharmacologic Actions

ClinicalTrials.gov processed this record on September 16, 2014